Southeast Clinical Oncology Research Consortium, Inc. (SCOR)

描述（由申请人提供）：SCCC-Upstate是两个成功的传统CCOPs的合并，即东南癌症控制联盟公司（SCCC）和北卡罗莱纳州（以下简称联盟），由23个组成部分和63个子组成部分组成，位于美国东南部的五州地区（GA， NC， SC， TN和VA），非临床行政办公室（AO）位于北卡罗来纳州温斯顿-塞勒姆。该财团通过向东南部农村地区提供服务，消除了一个关键障碍。AO提供专业知识、监管支持、培训、教育和主要研究人员，使小型农村社区医院、私人诊所和独立医生能够为患者提供临床试验。有了这种结构，农村中心将能够将学术产生的概念转化为现实世界。经济限制使大多数医院和私人诊所无法分配必要的资源独立开展研究。过去30年来，这种结构在支持农村社区方面取得了成功。这是医学博士查尔斯·L·斯珀尔的愿景，并被博士们发扬光大。阿特金斯和比尔登在病人的家庭社区进行临床试验。每个组成部分都有一个负责任的研究者和协调员来组织和促进临床研究的参与。位于86个治疗中心的232多名调查人员和140多名研究人员参与了在各种社区环境中的研究。广阔的地理区域为增加nci赞助的临床试验提供了机会。长期目标是：1)提供尖端的临床试验；2)实施加强癌症治疗的方案；3)在现有关系的基础上建立新的合作关系；4)积极招募临床试验参与者。这些组件的集水区面积超过950万，人口结构多样化，包括大量的非洲裔美国人。NCI对这笔拨款的支持将使有限的联邦资金在广大农村地区得到最大限度的利用，惠及农村和医疗服务不足的人口。

DESCRIPTION (provided by applicant): The SCCC-Upstate is a merger of two successful legacy CCOPs known as Southeast Cancer Control Consortium, Inc. (SCCC) and Upstate Carolina (hereafter the Consortium) comprised of 23 components and 63 sub-components, located in a five-state area of the Southeast US (GA, NC, SC, TN, and VA) with a nonclinical Administrative Office (AO) in Winston-Salem, NC. The Consortium eliminates a critical barrier by supplying service to the rural southeastern area. The AO provides expertise, regulatory support, training, education, and principal investigators to enable small rural community hospitals, private practices, and solo practitioners the ability to provide clinical trials to ther patients. With this structure, rural centers will be able to translate academic-generated concepts to the real world. Economic constraints prohibit most hospitals and private practices from allocating the required resources to conduct research independently. This structure has been successful in supporting rural communities for the past 30 years. This was the vision of Charles L Spurr, MD that has been carried on by Drs. Atkins and Bearden to make clinical trials available in the patient's home community. Each component has a responsible investigator and coordinator to organize and promote clinical research participation. Over 232 investigators and 140 research staff located at 86 treatment centers are involved in the delivery of research in a variety of community settings. The vast geographical area improves the opportunity to increase access of NCI-sponsored clinical trials. The long-term objectives are to: 1) provide cutting edge clinical trials; 2) implement programs to enhance cancer care delivery; 3) build on existing relationships and establish new collaborations; and 4) actively enroll participants to clinical trials. The catchment area of the components is over 9.5 million, with diverse demographics including a significant African American population. NCI support of this grant will allow restricted federal dollars to be maximized over a vast rural geographic area reaching rural and medically underserved populations.